ImmunoBiochem is an immuno-oncology biopharmaceutical company that has developed a disruptive approach to targeting unique proteins amplified in cancer secretomes. This approach enables selective and efficacious delivery of immunomodulatory and chemotherapeutic payloads into tumor cells, immune cells and tumor-supporting stroma within the tumor microenvironment. ImmunoBiochem has developed several biological therapeutics lead molecules for the treatment of intractable solid tumors.

Immunobiochem Corporation Logo



Event details

Date: June 10 - 17, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


30 in total